Mesenchymal stem cells therapy (Therapeutic Solutions International)
- Generic Name
- Mesenchymal stem cells therapy (Therapeutic Solutions International)
A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
Phase 1
Completed
- Conditions
- Recovery Following Partial Medial Meniscectomy
- Interventions
- First Posted Date
- 2005-09-23
- Last Posted Date
- 2021-12-27
- Lead Sponsor
- Mesoblast International Sàrl
- Target Recruit Count
- 60
- Registration Number
- NCT00225095
- Locations
- 🇺🇸
Orthopedic Center of Vero Beach, Vero Beach, Florida, United States
🇺🇸Ortholndy, Indianapolis, Indiana, United States
🇺🇸Greater Chesapeake Associates, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath